The global Growth Hormone Deficiency (GHD) Market, which was valued at USD 5.4 billion in 2023, is projected to grow significantly, reaching USD 8.5 billion by 2032 with an expected Compound Annual Growth Rate (CAGR) of 5.0% over the forecast period from 2024 to 2032. This growth trajectory is driven by advancements in growth hormone therapies, increased awareness of hormone deficiencies, and rising demand for effective treatments among pediatric and adult populations.Growth hormone deficiency is a condi...
more